Latest from the Press
Evidence-led reporting on kratom, cannabis, CBD, hemp, nootropics, and the rest of the alternative shelf.
-

Foundayo (Orforglipron) vs the Wegovy Pill: Two Obesity Pills Compared
-

Bacopa vs Lion’s Mane: What the Memory and Cognition Trials Show
-

GHK-Cu vs BPC-157: Copper Peptide and Gastric Peptide Compared
-

Turkey Tail vs Reishi: PSK, Cochrane Evidence and Safety Compared
-

Green Malay vs Green Maeng Da Kratom: What the Labels Really Tell You
-

Noopept vs Piracetam: Chemistry, Evidence and Legal Status Compared
-

Kava vs Kanna: How Two Calming Botanicals Differ on the Evidence
-

Ipamorelin vs Sermorelin: Two Growth Hormone Peptides on the Evidence
-

Retatrutide vs Semaglutide: Trial Data, Safety and Legal Status
-

Chaga vs Reishi: Evidence, Kidney and Liver Risks, and Label Traps
-

Borneo vs Bali Kratom: What the Labels Mean and What Lab Data Shows
-

Modafinil vs Adrafinil: Prodrug, Prescription Drug and the Liver Question
